Diabetologia

, Volume 35, Issue 2, pp 121–128 | Cite as

The influence of human C-peptide on renal function and glucose utilization in Type 1 (insulin-dependent) diabetic patients

  • B. -L. Johansson
  • S. Sjöberg
  • J. Wahren
Originals

Summary

The possible influence of C-peptide administration on renal function and whole body glucose utilization was examined in 11 patients (Group 1) with Type 1 (insulin-dependent) diabetes mellitus. They were given an i. v. insulin infusion during the night before the study and were euglycaemic at the time of examination. The glomerular filtration rate and effective renal plasma flow were measured by clearance techniques using constant-rate infusions of inulin and sodium para-aminohippurate. After baseline measurements C-peptide was infused during two periods of 60 min at rates of 5 and 30 pmol·kg−1·min−1. In a control study 0.9% NaCl was infused during two 60 min periods in ten Type 1 diabetic patients (Group 2), Glomerular filtration rate decreased by 7%(p<0.001), effective renal plasma flow increased by 3%, (p<0.05) and whole-body glucose utilization rose by approximately 25%(p<0.05) above basal during low-dose C-peptide infusion. Group 2 showed an unaltered glomerular filtration rate, effective renal plasma flow and glucose utilization during 60 min of NaCl infusion. The differences between Group 1 and Group 2 in glomerular filtration rate and glucose utilization were statistically significant. It is concluded that short-term administration of C-peptide in physiological amounts to patients with Type 1 diabetes may reduce the glomerular filtration rate and increase whole-body glucose utilization. The results suggest the possibility that short-term C-peptide administration may exert a regulatory influence on renal function and stimulate glucose utilization in Type 1 diabetic patients.

Key words

Glomerular filtration rate filtration fraction renal blood flow glomerular permeability 

References

  1. 1.
    Steiner DF (1978) On the role of the proinsulin C-peptide. Diabetes 27 [Suppl 1]: 145–148PubMedGoogle Scholar
  2. 2.
    Heding LG (1978) Insulin, C-peptide, and proinsulin in non-diabetics and insulin-treated diabetics. Diabetes 27 [Suppl 1]: 178–183PubMedGoogle Scholar
  3. 3.
    Blix PM, Boddie-Willis C, Landau RL, Rochman H, Rubenstein AH (1982) Urinary C-peptide: an indicator of beta-cell secretion under different metabolic conditions. J Clin Endocrinol Metab 54: 547–580PubMedGoogle Scholar
  4. 4.
    Stalder G, Schmid R (1959) Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood. Ann Paediatr 193: 129–138PubMedGoogle Scholar
  5. 5.
    Mogensen CE, Andersen MJF (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706–712PubMedGoogle Scholar
  6. 6.
    Mogensen CE (1972) Glomerular filtration rate and renal plasma flow in long-term juvenile diabetics without proteinuria. Br Med J 4: 257–259PubMedGoogle Scholar
  7. 7.
    Mogensen CE, Christensen CK, Beck Nielsen H, Vittinghus E (1983) Early changes in kidney function, blood pressure and the stages in diabetic nephropathy. In: Keen H, Legrain M (eds) Prevention and treatment of diabetic nephropathy. MTP press, Lancaster, pp 57–83Google Scholar
  8. 8.
    Mogensen CE, Andersen MJF (1974) Increased kidney size and glomerular filtration rate in untreated juvenile diabetes. Normalisation by insulin treatment. Diabetologia 11: 221–224Google Scholar
  9. 9.
    Sandahl-Christiansen J, Gammelgaard J, Tronier B, Svendsen PA, Parving HH (1982) Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 21: 683–688PubMedGoogle Scholar
  10. 10.
    Sandahl-Christiansen J, Frandsen M, Parving HH (1981) The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 20: 199–204PubMedGoogle Scholar
  11. 11.
    Østerby R, Gundersen HJG (1975) Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia 11: 225–229PubMedGoogle Scholar
  12. 12.
    Gundersen HJG, Østerby R (1977) Glomerular size and structure in diabetes mellitus. II. Late abnormalities. Diabetologia 13: 43–48PubMedGoogle Scholar
  13. 13.
    Friedman EA, Sheih S-D, Hirsch SR, Boshell BR (1981) No supranormal glomerular filtration (GFR) in type II (non-insulin-dependent) diabetes. Am Soc Nephrol 14: 102A (Abstract)Google Scholar
  14. 14.
    Schmitz A, Gundersen HJG, Østerby R (1988) Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Diabetes 37: 38–43PubMedGoogle Scholar
  15. 15.
    Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children and adults. J Paediatr 93: 62–66Google Scholar
  16. 16.
    Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548PubMedGoogle Scholar
  17. 17.
    Sjöberg S, Gunnarsson R, Gjötterberg M, Lefvert A-K, Person A, Östman J (1987) Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term insulin-dependent diabetes. Diabetologia 30: 208–213CrossRefPubMedGoogle Scholar
  18. 18.
    Hilger HH, Klumper JD, Ullrich KJ (1958) Wasserrückresorption und Ionentransport durch die Sammelrohrzellen der Säugetierniere. Pflugers Arch 267: 218–237PubMedGoogle Scholar
  19. 19.
    Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M (1945) The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 24: 388–404Google Scholar
  20. 20.
    DeFronzo RA, Tobin DT, Reubin R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223PubMedGoogle Scholar
  21. 21.
    Polonsky KS, Licinio-Paixao J, Given BD et al. (1986) Use of biosynthetic human C-peptide in the measurements of insulin secretion in normal volunteers and type 1 diabetic patients. J Clin Invest 77: 98–105PubMedGoogle Scholar
  22. 22.
    Hagen C, Faber OK, Binder C, Alberti KGMM (1977) Lack of metabolic effects of C-peptide in normal and juvenile diabetic patients. Acta Endocrinol 85 [Suppl 209]: 29A (Abstract)Google Scholar
  23. 23.
    Wallberg-Henriksson H, Andréasson K, Galuska D et al. (1989) C-peptide stimulates glucose transport in incubated normal muscle but not in muscles from type II diabetic patients. Diabetologia 32: 555A (Abstract)Google Scholar
  24. 24.
    Zierath JR, Thörne A, Johansson B-L, Wallberg-Henriksson H (1990) C-peptide stimulates glucose transport in type 1 diabetic skeletal muscle. Diabetes 39: 564A (Abstract)Google Scholar
  25. 25.
    Hoogwerf BJ, Bantle JP, Gaenslen HE et al. (1986) Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35: 122–125CrossRefPubMedGoogle Scholar
  26. 26.
    Wojcikowski Cz, Maier V, Dominiak K, Pfeiffer EF (1985) Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia 25: 288–290CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • B. -L. Johansson
    • 1
    • 3
  • S. Sjöberg
    • 2
  • J. Wahren
    • 1
    • 3
  1. 1.Department of Clinical Physiology, Karolinska InstituteHuddinge HospitalStockholmSweden
  2. 2.Department of Medicine, Karolinska InstituteHuddinge HospitalStockholmSweden
  3. 3.Department of Clinical PhysiologyKarolinska HospitalStockholmSweden

Personalised recommendations